Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06949423 · ClinicalTrials.gov registry record · NA
Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder
A NA study, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT06949423: Recruiting NA study, sponsored by Stanford University.
NCT06949423 is a NA study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06949423, a NA study, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of deep transcranial magnetic stimulation as a treatment for Veterans with Alcohol Use Disorder (AUD) to decrease the exceedingly high rate of relapse associated with this condition.
Primary Outcome
dACC activation to threat faces will be measured using fMRI during the FACES task, designed to assess emotional processing. Activation will be quantified as percent signal change from baseline (pre-treatment) to post-treatment scan.
Interventions
- DEVICE Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active
- DEVICE Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-12-17 |
| Est. Completion | 2030-06-30 |
| Phase | NA |
What NCT06949423 shows while recruiting
NCT06949423 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active is the first listed.
NCT06949423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06949423 about?
NCT06949423 is a clinical study titled "Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder". The purpose of this study is to evaluate the efficacy of deep transcranial magnetic stimulation as a treatment for Veterans with Alcohol Use Disorder (AUD) to decrease the exceedingly high rate of relapse associated with this condition.
What is the current status of trial NCT06949423?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-12-17. Estimated completion is 2030-06-30.
What interventions are being tested in trial NCT06949423?
The interventions under investigation include: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active (DEVICE), Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Sham (DEVICE).
Who is sponsoring clinical trial NCT06949423?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06949423's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI